The effect of thiazolidinediones on adiponectin serum level: a meta‐analysis
- 21 July 2007
- journal article
- review article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 10 (5), 367-375
- https://doi.org/10.1111/j.1463-1326.2007.00755.x
Abstract
Adiponectin is a hormone mainly produced by white adipose tissue. Decreased levels of adiponectin are linked with visceral obesity, insulin resistance states, and cardiovascular diseases. Recently, several studies have pointed out an increase in adiponectin serum levels in subjects undergoing treatment with thiazolidinediones (TZD). The aim of this study is to systematically review the current state of evidence of the effect of TZD on adiponectin serum level with special attention to avoid publication bias.An extensive literature search was performed. Meta Analysis Version 2.0 computer program was used to calculate statistical differences in means and 95% confidence interval (CI). Publication bias was assessed using different statistical approaches.In the meta-analysis including 19 studies the overall standardized mean difference was 0.94 (95% CI, 0.81-1.06) which means that subjects treated with TZDs on average had means of adiponectin concentration that were about 1 standard deviation higher than the comparison groups even after controlling for possible biases.The results obtained agree with a moderate increase of serum adiponectin. The results clearly reveal an increase of endogenous serum adiponectin levels by intake of TZDs and may point to a potential new option to manage obesity-related diseases.This publication has 46 references indexed in Scilit:
- Systematic review: adipose tissue, obesity and gastrointestinal diseasesAlimentary Pharmacology & Therapeutics, 2006
- Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Increased plasma adiponectin in response to pioglitazone does not result from increased gene expressionAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Review article: adipocytokines and insulin resistanceAlimentary Pharmacology & Therapeutics, 2005
- Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart FailureCirculation, 2005
- Keynote review: The adipocyte as a drug discovery targetDrug Discovery Today, 2005
- An increase in insulin sensitivity and basal beta‐cell function in diabetic subjects treated with pioglitazone in a placebo‐controlled randomized studyDiabetic Medicine, 2004
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002
- Statistical methods for assessing the influence of study characteristics on treatment effects in ‘meta‐epidemiological’ researchStatistics in Medicine, 2002